文献速递神经肿瘤神经重症

成人原发性中枢神经系统肿瘤治疗并发症的诊断与管理

Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults.
PubMed 文献 · Neuro Oncol · 2023-01-01

欧洲神经肿瘤学会(EANO)制定共识推荐,针对成人原发性中枢神经系统肿瘤(除外淋巴瘤)患者,聚焦手术、放疗和药物治疗相关不良反应与并发症的预防、诊断和管理。推荐涵盖药物治疗的剂量调整、中断和再暴露,并总结不必要、无效或禁忌的干预措施,旨在为临床试验内外的标准治疗提供参考。

要点

  • EANO发布共识,针对成人原发性中枢神经系统肿瘤(除外淋巴瘤)治疗并发症的预防、诊断和管理提供推荐。
  • 推荐聚焦手术、放疗和药物治疗,涵盖药物治疗的剂量调整、中断和再暴露方案。
  • 共识总结不必要、无效或禁忌的干预措施,为临床试验内外标准治疗提供参考。

核心结论

  • EANO制定共识推荐,用于预防、诊断和管理成人原发性中枢神经系统肿瘤(除外淋巴瘤)治疗相关不良反应与并发症,聚焦手术、放疗和药物治疗。

研究设计与样本

  • 欧洲神经肿瘤学会(EANO)制定共识文件,针对成人原发性中枢神经系统肿瘤(除外淋巴瘤)患者群体,聚焦手术、放疗和药物治疗相关不良反应与并发症。

主要发现

  • 中枢神经系统肿瘤患者常接受多模式治疗,其不良反应和并发症尚未被系统研究,但在临床实践中构成重大挑战并影响功能和生活质量,尤其在长期脑肿瘤幸存者管理中。

关键数值与推荐

  • 共识提供药物治疗的剂量调整、中断和再暴露推荐,可作为临床试验中标准治疗管理的参考。
  • 共识总结哪些干预措施不必要、无效或禁忌。

临床怎么用

  • 该共识文件可作为临床试验内外标准治疗实施的参考。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Central nervous system (CNS) tumor patients commonly undergo multimodality treatment in the course of their disease. Adverse effects and complications from these interventions have not been systematically studied, but pose significant challenges in clinical practice and impact function and quality of life, especially in the management of long-term brain tumor survivors. Here, the European Association of Neuro-Oncology (EANO) has developed recommendations to prevent, diagnose, and manage adverse effects and complications in the adult primary brain CNS tumor (except lymphomas) patient population with a specific focus on surgery, radiotherapy, and pharmacotherapy. Specifically, we also provide recommendations for dose adaptations, interruptions, and reexposure for pharmacotherapy that may serve as a reference for the management of standard of care in clinical trials. We also summarize which interventions are unnecessary, inactive or contraindicated. This consensus paper should serve as a reference for the conduct of standard therapy within and outside of clinical trials.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Weller M, Le Rhun E, Van den Bent M, et al. Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults. Neuro Oncol. 2023. PMID: 36843451. doi:10.1093/neuonc/noad038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。